F4+ E. coli Strain for Animal Growth Promotion

The patent uses probiotic bacteria (Lactobacillus acidophilus, Lactococcus lactis, or Enterococcus faecium) as intermediary organisms to mediate the growth promotion effect. These probiotics compete with pathogenic bacteria, produce beneficial metabolites, and stimulate the animal's immune system, thereby promoting growth without using antibiotics. This intermediary approach eliminates antibiotic resistance and environmental contamination while maintaining growth promotion benefits.

The patent changes the fundamental parameter from chemical growth promoters (antibiotics) to biological growth promoters (probiotics). This parameter change involves using live bacterial cultures with specific physiological properties rather than chemical substances, thereby achieving growth promotion through biological mechanisms such as competitive exclusion, enzyme production, and immune modulation, which do not lead to resistance or contamination.

The patent replaces heavy metal additives with probiotic bacteria as intermediary organisms that naturally occur in the animal's digestive system. These probiotics act as living catalysts that improve nutrient absorption, reduce inflammation, and enhance overall gut health, thereby promoting growth without introducing toxic substances into the environment or animal tissues.

The patent converts the concept of using harmful substances (heavy metals) into using beneficial living organisms (probiotics). Instead of adding toxic elements that accumulate in the environment, the patent introduces beneficial bacteria that improve animal health through natural biological processes, thereby converting a harmful approach into a beneficial one.

The patent uses probiotic bacteria as intermediary organisms that provide disease prevention through multiple mechanisms: competitive exclusion of pathogenic bacteria, production of antimicrobial substances (bacteriocins, organic acids), stimulation of the animal's immune system, and maintenance of gut barrier integrity. This biological approach prevents disease without selecting for antibiotic resistance.

The patent enables the animal's digestive system to serve itself by introducing probiotics that colonize the gut and provide ongoing protection against diseases. These probiotics establish a sustainable protective mechanism within the animal's own microbiome, reducing the need for external antibiotic interventions and allowing the animal's immune system to develop naturally.